Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 350

Sort by

Sort Order Select

Journal Articles

How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia

Ibrahim Aldoss, Dan Douer

Blood (2020) 135 (13): 987–995.

https://doi.org/10.1182/blood.2019002477

Published: 2020

Journal Articles

Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel

Nirmish Shah, David Beenhouwer, Michael S Broder, MD MSHS, Lanetta Bronte-Hall, Laura De Castro, MD MHSc, Sarah N Gibbs, Victor R Gordeuk, MD, Julie Kanter, MD, Elizabeth S Klings, MD, Thokozeni Lipato, MD, Deepa Manwani, MD, Brigid Scullin, Irina Yermilov, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 415.

https://doi.org/10.1182/blood-2019-121556

Published: 2019

Journal Articles

Pediatric Hematologist/Oncologists' Beliefs about Hematopoietic Stem Cell Transplant for Children with Sickle Cell Disease: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) Study

Emily Riehm Meier, MD MSHS, Allistair Abraham, MD, Alexander I. Ngwube, MD, Isaac Janson, PhD, Gregory M.T. Guilcher, MD, John T. Horan, MDMPH, Kimberly A. Kasow, DO

Blood (2019) 134 (Supplement_1): 2164.

https://doi.org/10.1182/blood-2019-130543

Published: 2019

Journal Articles

Mentorship Experiences Among Second-Year U.S. Hematology/Oncology Fellows in the 2019 ASH Hematology/Oncology Fellows Survey

Alfred I Lee, MD PhD, Leah E Masselink, PhD, Emily Bass, Nathan T. Connell, MD MPH, Ariela L. Marshall, MD, Clese E Erikson, MPAff

Blood (2019) 134 (Supplement_1): 2124.

https://doi.org/10.1182/blood-2019-132252

Published: 2019

Journal Articles

Late Effects Are Important Considerations in Initial Hodgkin Lymphoma Treatment Decision-Making According to Survivors

Anita J Kumar, MDMS, Rachel Murphy-Banks, MA, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP

Blood (2019) 134 (Supplement_1): 2137.

https://doi.org/10.1182/blood-2019-124481

Published: 2019

Journal Articles

Perceptions of Community Hematologists/Oncologists on Barriers to Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Diffuse Large B-Cell Lymphoma

Ajeet Gajra, MD FACP, Richard Sweat, PhD, Yolaine Jeune-Smith, PhD, Jonathan K. Kish, PhD MPH, Bruce A Feinberg, DO

Blood (2019) 134 (Supplement_1): 2198.

https://doi.org/10.1182/blood-2019-127741

Published: 2019

Journal Articles

Tyrosine Kinase Inhibitor Therapy Discontinuation in Clinical Practice in Chronic Myeloid Leukemia - a US Physician Survey Conducted after Guideline Updates

Ehab L. Atallah, MD, Islam Sadek, Xiting Cao, Dominick Latremouille-Viau, Irina Pivneva, PhD, Carmine Rossi, Annie Guerin, Vamsi Kota, MBBS

Blood (2019) 134 (Supplement_1): 2208.

https://doi.org/10.1182/blood-2019-125736

Published: 2019

Journal Articles

Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase

Blood (2019) 134 (Supplement_1): 2148.

https://doi.org/10.1182/blood-2019-125068

Published: 2019

Journal Articles

Provider Practices Regarding Prophylactic Anticoagulation in Children with Leukemia

Nicole Kucine, MD, Melanie Degliuomini, MD, Elizabeth Mauer, MS, Victoria Cooley, MS, Linda M Gerber, PhD, Suchitra Acharya, MD

Blood (2019) 134 (Supplement_1): 3412.

https://doi.org/10.1182/blood-2019-123084

Published: 2019

Journal Articles

Training Pediatric Hematologists / Oncologists for Capacity Building in Ethiopia

Daniel Hailu, MD, Haileyesus Adamu, MD, Diriba Fufa, MD, Doreen Karimi, MD, Thomas Alexander, MDMPH, Catherine Habashy, MD MPH, Amit Dotan, MD, Rabia M Wali, FCPS, MBBS, Prasanna N Kumar, MD, Miguel Bonilla, MD, Wondwessen Bekele, MD, Sheila Weitzman, MD, Julie Broas, JD, David N Korones, MD, Aziza T Shad, MD

Blood (2019) 134 (Supplement_1): 3423.

https://doi.org/10.1182/blood-2019-121796

Published: 2019

Journal Articles

Patterns of Care and Clinical Outcomes in Peripheral T-Cell Lymphoma Patients Receiving First-Line Treatment in Routine Clinical Practice in France and the United Kingdom

Christopher P Fox, MBChB(Hons), MRCP, FRCPath, PhD, Ajibade O Ashaye, MD MBA, MPH, MSc., Ruchit Shah, PhD, Shelby Corman, PharmD, MS, BCPS, Mehul Dalal, PhD, Lorenz Truemper, MD

Blood (2019) 134 (Supplement_1): 3482.

https://doi.org/10.1182/blood-2019-127289

Published: 2019

Journal Articles

Large Impact of Continuing Medical Education on Community Hem/Oncs and Educational Gaps in Multiple Myeloma

Lauren Willis, PharmD, Pan Chen, PhD, Katie S Lucero, PhD MS, BS

Blood (2019) 134 (Supplement_1): 3489.

https://doi.org/10.1182/blood-2019-124836

Published: 2019

Journal Articles

Cytogenetic and Molecular Response with First- and Second-Generation Tyrosine Kinase Inhibitor (TKI) Therapy in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML)

Jorge E. Cortes, MD, Clara Chen, PhD BS, MS, Catherine Davis, PharmD, Stuart L. Goldberg, MD, Michael J. Mauro, MD

Blood (2019) 134 (Supplement_1): 2929.

https://doi.org/10.1182/blood-2019-127959

Published: 2019

Journal Articles

Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)

Yan Leyfman, BS, Erel Joffe, MDMSc, Esther Drill, PhD, Sridevi Rajeeve, MD, Andrew D. Zelenetz, MD PhD, Maria Lia Lia Palomba, Craig H. Moskowitz, Carol S. Portlock, MD, Ariela Noy, MD, Steven M. Horwitz, MD, Alison J. Moskowitz, MD, Paul A. Hamlin, MD, Matthew J Matasar, MD, Anita Kumar, MD, Gottfried R. von Keudell, MD PhD, Connie Lee Batlevi, MD PhD, Anas Younes, MD, David J. Straus, MD

Blood (2019) 134 (Supplement_1): 2826.

https://doi.org/10.1182/blood-2019-123257

Published: 2019

Journal Articles

Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia

Marlise Luskin, MDMS, Eric Zhou, PhD, Zilu Zhang, MS, Daniel J. DeAngelo, MD PhD, Richard Stone, MD, Martha Wadleigh, MD, Jacqueline S Garcia, MD, Eric S. Winer, MD, Christopher Recklitis, PhD, Kelsey O'Day, Victoria Lapiana, Ryan Osborn, David P. Steensma, MD, Gregory A. Abel, MDMPH

Blood (2019) 134 (Supplement_1): 4786.

https://doi.org/10.1182/blood-2019-125147

Published: 2019

Journal Articles

Understanding Clinician and Patient Preferences about Novel Agents in Chronic Lymphocytic Leukemia

Hannah Le, PharmD, MPH, Trudy Pendergraft, MSPH, Svea K. Wahlstrom, VMD, MS, Kellie Ryan, MPH, Laura Sarokin, PhD, Emily Mulvihill, MBA, Thomas Campbell, PhD, Martine C. Maculaitis, PhD, Thomas W. LeBlanc, MDMA,MHS

Blood (2019) 134 (Supplement_1): 4730.

https://doi.org/10.1182/blood-2019-129606

Published: 2019

Journal Articles

Improving End of Life Care for Hematology-Oncology Patients within the Rossy Cancer Network

Victoria Korsos, BSc, Allaa Ali, MPH, Doneal Thomas, M.Phil, M.Sc, Kelly L. Davison, MD PhD, Sarit Assouline, MD, Luca Petruccelli, Chantal Cassis, MD

Blood (2019) 134 (Supplement_1): 4775.

https://doi.org/10.1182/blood-2019-129428

Published: 2019

Journal Articles

Hematologist Experiences and Perceptions of Outpatient Management of Adult Patients with Sickle Cell Disease

Jennifer Yui, MD, Farzana Sayani, MD, Marilyn Schapira, MD

Blood (2019) 134 (Supplement_1): 4710.

https://doi.org/10.1182/blood-2019-131611

Published: 2019

Journal Articles

Perceptions of Community Hematologists/Oncologists on the Potential of Data Presented at ASH 2018 and ASCO 2019 to Alter the Standard of Care for Multiple Myeloma Treatment

Ajeet Gajra, MD FACP, Richard Sweat, PhD, Yolaine Jeune-Smith, PhD, Bruce Feinberg, DO

Blood (2019) 134 (Supplement_1): 5822.

https://doi.org/10.1182/blood-2019-129502

Published: 2019

Journal Articles

A Novel Method for Identifying Transgender and Gender Diverse Patients with Lymphoma: A Single Center Experience

Alison B Alpert, MD MFA, Shea A Nagle, Manuel J Greer, Philip J Meacham, MS, Peter Macdowell, MS, Nicholas Gerbino, Myla Strawderman, MS, Kyle Trenshaw, PhD, Tina Faugh, Carla Casulo

Blood (2019) 134 (Supplement_1): 5825.

https://doi.org/10.1182/blood-2019-126884

Published: 2019

NARROW

How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia

Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel

Pediatric Hematologist/Oncologists' Beliefs about Hematopoietic Stem Cell Transplant for Children with Sickle Cell Disease: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) Study

Mentorship Experiences Among Second-Year U.S. Hematology/Oncology Fellows in the 2019 ASH Hematology/Oncology Fellows Survey

Late Effects Are Important Considerations in Initial Hodgkin Lymphoma Treatment Decision-Making According to Survivors

Perceptions of Community Hematologists/Oncologists on Barriers to Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Diffuse Large B-Cell Lymphoma

Tyrosine Kinase Inhibitor Therapy Discontinuation in Clinical Practice in Chronic Myeloid Leukemia - a US Physician Survey Conducted after Guideline Updates

Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase

Provider Practices Regarding Prophylactic Anticoagulation in Children with Leukemia

Training Pediatric Hematologists / Oncologists for Capacity Building in Ethiopia

Patterns of Care and Clinical Outcomes in Peripheral T-Cell Lymphoma Patients Receiving First-Line Treatment in Routine Clinical Practice in France and the United Kingdom

Large Impact of Continuing Medical Education on Community Hem/Oncs and Educational Gaps in Multiple Myeloma

Cytogenetic and Molecular Response with First- and Second-Generation Tyrosine Kinase Inhibitor (TKI) Therapy in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML)

Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)

Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia

Understanding Clinician and Patient Preferences about Novel Agents in Chronic Lymphocytic Leukemia

Improving End of Life Care for Hematology-Oncology Patients within the Rossy Cancer Network

Hematologist Experiences and Perceptions of Outpatient Management of Adult Patients with Sickle Cell Disease

Perceptions of Community Hematologists/Oncologists on the Potential of Data Presented at ASH 2018 and ASCO 2019 to Alter the Standard of Care for Multiple Myeloma Treatment

A Novel Method for Identifying Transgender and Gender Diverse Patients with Lymphoma: A Single Center Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only